eli lilly retatrutide press release 2024 2025 Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial Retatrutide, Eli Lilly's next obesity
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15


























